Mounjaro Mounjaro tirzepatide Eli Lilly GLP-1 GIP GLP-1 Mounjaro GLP-1 GIP GLP-1 Glucagon-like peptide-1-1 GIP Glucose-dependent Insulinotropic Polypeptide- 028800-028805 BMI 30 BMI 27 MTC NEJM SURMOUNT-1 8 12 5% 72 1 15 mg/ 20.9% GLP-1 semaglutide 14% SURPASS 10 mg 40 8.8 HbA1c 23 6 812 5% 40 8.8 NEJM, 2021 72 20.9%NEJM, 2022 // 10 3 5 2.5 mg5 mg7.5 mg10 mg12.5 mg15 mg 4 2.5 mg 4 5 mg 5 7.5 10 12.5 15 mg 1 2/3 GLP-1 15mg 5mg 46 FDA Tirzepatide 28C 21 0C QA 36 47 2448
We encourage you to schedule an appointment if: Your period is delayed by more than 90 days (three months) You miss periods frequently or have irregular cycles You experience severe pain, abnormal bleeding, or other symptoms of hormonal imbalance While a mild delay in your period is often nothing to worry about, persistent or significant changes in your menstrual cycle should be evaluated
In a head-to-head comparison of the two GLP-1 drugs, adults living with obesity or overweight who were taking Zepbound, the brand name for tirzepatide, lost more than 20% of their weight on average after about a year and half, compared with an average of about 14% weight loss among those taking Wegovy, the brand name for semaglutide
References: Semeco A
23 bites of chicken Half yogurt cup One egg String cheese Half protein shake Cottage cheese crackers Turkey roll-up Soft tofu in broth A tiny anchor is not glamorous
